MedTrace Logo

Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

NCT02217267 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2022-11-30

No results posted yet for this study

Summary

The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 months after first time of infusion

Conditions

Interventions

DRUG

Lidocaine

Lidocaine 3 mg/kg dilute in Normal Saline to 50 ml intravenous infusion in 1 hour

DRUG

Placebo

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Suratsawadee Wangnamthip, M.D. · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2017-12-29
Completion
2018-02-28

Countries

  • Thailand

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217267 on ClinicalTrials.gov